ReviewCurrent pharmaceutical design2014
Targeting SREBP-1-driven lipid metabolism to treat cancer.
Deliang Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
186 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewCurrent pharmaceutical design2014
Deliang Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.